LORD, ABBETT & CO. LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 728100
JERSEY CITY, NJ
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$82,745,780
+$8,392,852 QoQ
Shares Held
166,581
+0.0% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#124
of 1,735 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LORD, ABBETT & CO. LLC holds $1,234,584,311 across 31 Biotechnology names. VRTX ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
281,500 | $151,151,425 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
789,241 | $147,809,054 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
3,431,030 | $132,780,861 | |
| 4 | ARGX |
Argenx SE
|
108,253 | $100,433,885 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
166,581 | $82,745,780 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
540,977 | $63,332,177 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
398,994 | $48,908,684 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
590,074 | $48,132,336 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,745,780 | 166,581 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $74,352,928 | 166,509 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $699,854 | 1,572 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,428,764 | 2,947 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,254,410 | 3,115 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,524,997 | 3,279 | Shares | Other | 2024-12-13 | |
| 2024-06-30 | $1,396,316 | 2,979 | Shares | Sole | 2024-10-07 | |
| 2024-03-31 | $51,943,175 | 124,263 | Shares | Other | 2024-10-07 | |
| 2023-12-31 | $51,502,100 | 126,575 | Shares | Other | 2024-10-07 | |
| 2023-09-30 | $79,549,697 | 228,762 | Shares | Other | 2024-10-07 | |
| 2023-06-30 | $81,139,184 | 230,568 | Shares | Other | 2024-10-07 | |
| 2023-03-31 | $60,051,711 | 190,598 | Shares | Other | 2024-10-07 | |
| 2022-12-31 | $110,887,765 | 383,987 | Shares | Other | 2024-10-07 | |
| 2022-09-30 | $160,574,830 | 554,586 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $150,152,364 | 532,852 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $167,909,923 | 643,407 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $23,928,641 | 118,676 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $26,948,280 | 125,405 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $59,926,134 | 253,559 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $114,990,019 | 422,571 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $120,914,694 | 416,502 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $121,630,283 | 511,159 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||